Cefiderocol study in burn injury patients
Treatments studied
Part of Infections, Injuries & trauma clinical trials.
This trial tests how the antibiotic cefiderocol works in burn patients. It aims to ensure the drug is safe and effective for treating infections in people with severe burns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- Your kidney function is normal or near normal (estimated clearance of 60 mL/min or higher)
- You do not have acute kidney injury at the start of the study
- You do not have HIV or hepatitis B infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an IV antibiotic (cefiderocol/xeruborbactam) in people with different levels of kidney function, including those on dialysis. It aims to see how the drug is processed by the body and whether it is safe.
This trial looks at how well the antibiotic cefiderocol works against a type of Klebsiella bacteria that is hard to treat and more likely to cause severe infections. It may help find better treatments for patients with these infections.
This trial tests a special blood filter called Efferon LPS that removes harmful substances from the blood of people with severe burns. It aims to help the body recover by reducing inflammation and infection.
This trial tests how well different treatments (like aloe vera, silver, and an antibiotic called dalbavancin) prevent and treat infections in people with frostbite. It also studies how these medicines work in the body.
This Phase 3 study tests whether giving preventive antibiotics lowers infection risk when you need surgery to remove burned skin and place a skin graft. It may help patients heal with fewer serious infections, but it also depends on your antibiotic allergy and current health status.
This study collects tissue and data from burn patients to build a better tool for predicting sepsis, a serious infection. If you qualify, your participation could help improve care for future burn patients.
Hear when a new Drug Clearance After Severe Burn Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.